title: Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
authors.forename: K
authors.initials: K
authors.lastname: Toledo Perdomo
authors.forename: R
authors.initials: R
authors.lastname: Ortega Salas
authors.forename: M J
authors.initials: MJ
authors.lastname: Pérez-Sáez
authors.forename: E
authors.initials: E
authors.lastname: Esquivias de Motta
authors.forename: M
authors.initials: M
authors.lastname: Espinosa Hernández
authors.forename: M
authors.initials: M
authors.lastname: López Andreu
authors.forename: F
authors.initials: F
authors.lastname: López Rubio
authors.forename: P
authors.initials: P
authors.lastname: Aljama García
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D001324:Autoantigens / Q000276:immunology*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D050533:Glomerular Basement Membrane / Q000276:immunology*; D005921:Glomerulonephritis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010956:Plasmapheresis; D006435:Renal Dialysis
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D001324:Autoantigens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone